UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration

Circulation (New York, N.Y.), 2020-04, Vol.141 (15), p.1249-1265

2020

Volltextzugriff (PDF)

Melanoma MicroRNA Signature Predicts Post-Recurrence Survival

Clinical cancer research, 2010-03, Vol.16 (5), p.1577-1586

2010

Volltextzugriff (PDF)

BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy

Cancer research (Chicago, Ill.), 2013-10, Vol.73 (20), p.6264-6276

2013

Volltextzugriff (PDF)

A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis

Clinical cancer research, 2015-11, Vol.21 (21), p.4903-4912

2015

Volltextzugriff (PDF)

miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis

Cancer cell, 2011-07, Vol.20 (1), p.104-118

2011

Volltextzugriff (PDF)

In Vivo miRNA Decoy Screen Reveals miR-124a as a Suppressor of Melanoma Metastasis

Frontiers in oncology, 2022-04, Vol.12, p.852952-852952

2022

Volltextzugriff (PDF)

The transformative role of digital health platforms: Bridging diversity gaps in cancer care in younger patient populations

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13503-e13503

2024

Volltextzugriff (PDF)

Bridging the gap: Leveraging AI to enhance access to clinical trials for underrepresented and underserved populations with cancer

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13701-e13701

2024

Volltextzugriff (PDF)

miRNA-mediated GALNT modulation of invasion and immune suppression: A sweet deal for metastatic cells

Oncoimmunology, 2012-08, Vol.1 (5), p.746-748

2012

Volltextzugriff (PDF)

Barriers to diversity in cancer therapy: Uncovering disparities in knowledge and interpretation of genetic testing among African Americans, and their direct implications for access to mutation-based therapies

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18587-e18587

2023

Volltextzugriff (PDF)

ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1

Experimental cell research, 2009-05, Vol.315 (8), p.1490-1504

2009

Volltextzugriff (PDF)

ECOG score as a barrier for clinical trial eligibility in the patient population with genitourinary cancer: Is it time to adapt this criterion to real-world data?

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.78-78

2023

Volltextzugriff (PDF)

Patients with prostate cancer consider clinical trial options significantly earlier in their journey compared to patients with other solid tumors

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.305-305

2024

Volltextzugriff (PDF)

In vivo Modeling and Molecular Characterization: A Path Toward Targeted Therapy of Melanoma Brain Metastasis

Frontiers in oncology, 2013-01, Vol.3, p.127-127

2013

Volltextzugriff (PDF)

Can an artificial intelligence-based platform reduce physician burden and increase access to clinical trials?

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1552-1552

2022

Volltextzugriff (PDF)

Abstract PO3-10-07: Leveraging AI to identify factors influencing access to care and their association with overall survival- a multiracial Breast Cancer cohort

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO3-10-07-PO3-10-07

2024

Volltextzugriff (PDF)

Abstract A119: Unveiling disparities in clinical trial participation: Exploring socioeconomic barriers and access to insurance among diverse ethnic groups

Cancer epidemiology, biomarkers & prevention, 2023-12, Vol.32 (12_Supplement), p.A119-A119

2023

Volltextzugriff (PDF)

Profound impact of ECOG performance status on clinical trial eligibility and access: Diverging effects by cancer type

JCO global oncology, 2023-08, Vol.9 (Supplement_1), p.97-97

2023

Volltextzugriff (PDF)

Development and characterization of a clinically relevant mouse model of melanoma brain metastasis

Pigment cell and melanoma research, 2013-09, Vol.26 (5), p.743-745

2013

Volltextzugriff (PDF)

Abstract P2-13-05: Triple Negative Breast Cancer (TNBC) patients are more likely to digitally explore clinical trial options and prior to receiving treatment for advanced disease compared to non-TNBC patients

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P2-P2-13-05

2023

Volltextzugriff (PDF)

MicroRNAs dysregulation in melanoma progression and brain metastasis

Gaziel, Avital

2012

Volltextzugriff (PDF)

Abstract 1946: Identification of miRNAs that contribute to melanoma brain metastasis

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1946-1946

2010

Volltextzugriff (PDF)

Krüppel-like factor 4 (KLF4) regulates the miR-183~96~182 cluster under physiologic and pathologic conditions

Oncotarget, 2017-04, Vol.8 (16), p.26298-26311

2017

Volltextzugriff (PDF)

Abstract A10: BRD4 is a new therapeutic target in melanoma

Cancer research (Chicago, Ill.), 2013-07, Vol.73 (13_Supplement), p.A10-A10

2013

Volltextzugriff (PDF)

Targeting BET proteins in melanoma: A novel treatment approach

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.9091-9091

2013

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(24)
Dissertationen
(1)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration

Melanoma MicroRNA Signature Predicts Post-Recurrence Survival

BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy

A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis

miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis

In Vivo miRNA Decoy Screen Reveals miR-124a as a Suppressor of Melanoma Metastasis

The transformative role of digital health platforms: Bridging diversity gaps in cancer care in younger patient populations

Bridging the gap: Leveraging AI to enhance access to clinical trials for underrepresented and underserved populations with cancer

miRNA-mediated GALNT modulation of invasion and immune suppression: A sweet deal for metastatic cells

Barriers to diversity in cancer therapy: Uncovering disparities in knowledge and interpretation of genetic testing among African Americans, and their direct implications for access to mutation-based therapies

ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1

ECOG score as a barrier for clinical trial eligibility in the patient population with genitourinary cancer: Is it time to adapt this criterion to real-world data?

Patients with prostate cancer consider clinical trial options significantly earlier in their journey compared to patients with other solid tumors

In vivo Modeling and Molecular Characterization: A Path Toward Targeted Therapy of Melanoma Brain Metastasis

Can an artificial intelligence-based platform reduce physician burden and increase access to clinical trials?

Abstract PO3-10-07: Leveraging AI to identify factors influencing access to care and their association with overall survival- a multiracial Breast Cancer cohort

Abstract A119: Unveiling disparities in clinical trial participation: Exploring socioeconomic barriers and access to insurance among diverse ethnic groups

Profound impact of ECOG performance status on clinical trial eligibility and access: Diverging effects by cancer type

Development and characterization of a clinically relevant mouse model of melanoma brain metastasis

Abstract P2-13-05: Triple Negative Breast Cancer (TNBC) patients are more likely to digitally explore clinical trial options and prior to receiving treatment for advanced disease compared to non-TNBC patients

MicroRNAs dysregulation in melanoma progression and brain metastasis

Abstract 1946: Identification of miRNAs that contribute to melanoma brain metastasis

Krüppel-like factor 4 (KLF4) regulates the miR-183~96~182 cluster under physiologic and pathologic conditions

Abstract A10: BRD4 is a new therapeutic target in melanoma

Targeting BET proteins in melanoma: A novel treatment approach

Suchergebnisse filtern